Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Thrombocytopenia
•
Hematology
•
Benign Hematology
•
Hospital Medicine
In a critically ill patient with TMA, intermediate-risk PLASMIC score, and severe vitamin B12 deficiency, would you perform plasma exchange while awaiting ADAMTS13 testing?
Intermediate risk PLASMIC score
Related Questions
Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?
How would you manage anticoagulation in a patient with acute MI or PE with prolonged aPTT due to congenital factor XII deficiency?
How would you manage presumed gestational thrombocytopenia with moderate thrombocytopenia for delivery planning?
Do you routinely screen and replace Vitamin D in patients with ITP?
How would you manage ITP in patients who develop cirrhosis and hemorrhage?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
How do you manage patients with embolic stroke of an undetermined source and a papillary fibroelastoma found on an echocardiogram?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
How do you start and manage therapeutic SC heparin for acute thrombosis in pregnancy as the patient approaches delivery?
Are there data to support full-dose anticoagulation added to an antiplatelet in recurrent peripheral arterial thrombosis requiring revascularization and stenting?